MRSA and VRE: Preventing patient-to-patient spread

Infections in Medicine

Volumn 20, Issue 4, 2003, Pages 194-200

  Salgado, Cassandra D ^a   Farr, Barry M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Methicillin resistant Staphylococcus aureus; Nosocomial infection; Preventive medicine; Vancomycin resistant Enterococcus

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; DISINFECTION; DRUG USE; ENTEROCOCCUS; HAND WASHING; HEALTH CARE COST; HOSPITAL; HOSPITAL INFECTION; HUMAN; INSTRUMENT STERILIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; UNITED STATES;

EID: 0037396480     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. National Nosocomial Infections Surveillance (NNIS) System. NNIS System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;27:520-532.
2. Stosor V, Peterson L, Postelnick M, Noskin G. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med. 1998;158:522-527.
3. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol. 1999, 20:408-411.
4. Cosgrove S, Perencevich E, Sakoulas G, et al. Mortality related to methicillin-resistant bacteremia compared to methicillin-sensitive bacteremia. In: Program and abstracts of the 11th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 1-3, 2001; Toronto. Abstract 96.
5. Salgado C, Farr B. The cost of vancomycin-resistance: a meta-analysis. In: Program and abstracts of the 12th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 6-9, 2002; Salt Lake City. Abstract 113.
6. Marty L, Flahault A, Suarez B, et al. Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteremic cancer patients. Intensive Care Med. 1993;19:285-289.
7. Webb M, Riley LW, Roberts RB. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clin Infect Dis. 2001; 33:445-452.
8. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am. 1997;11:757-765.
9. Zachary KC, Bayne PS, Morrison V, et al. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2001;22:560-564.
10. Boyce JM, Chenevert C. Isolation gowns prevent health care workers (HCWs) from contaminating their clothing, and possibly their hands, with methicillin-resistant Staphylococcus aureus (MRSA) and resistant enterococci. In: Program and abstracts of the 8th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 5-7,1998; Orlando, Fla. Abstract S74.
11. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol. 1997;18:622-627.
12. Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet. 1996;348:1615-1619.
13. Jernigan JA, Titus MG, Groschel DH, et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol. 1996;143:496-504.
14. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis. 1995;171:614-624.
15. Thompson RL, Cabezudo I, Wenzel RP. Epidemiodology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982;97:309-317.
16. Murray-Leisure K, Geib S, Graceley D, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 1990;11:343-350.
17. Byers K, Anglim. A, Anneski C, et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol. 2001;22:140-147.
18. Boyce J, Opal SM, Chow JW, et al. Outbreak of multi-drug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994;32:1148-1153.
19. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16:750-755.
20. Anglim AM, Klym B, Byers KE, et al. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium. Arch Intern Med. 1997;157:1132-1136.
21. Dembry L, Uzokwe K, Zervos M. Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol. 1996;17:286-292.
22. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20:1126-1133.
23. Morris JG, Shay D, Hebden J, et al. Enterococci resistant to multiple antimicrobial agents including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 1995;123:250-259.
24. Quale J, Landman D, Atwood E, et al. Experience with a hospital-wide outbreak of vancomycin-resistant enterococci. Am J Infect Control. 1996;24:372-379.
25. de Lencastre H, Brown AE, Chung M, et al. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City hospital. Microb Drug Resist. 1999;5:113-129.
26. Salgado C, Sherertz R, Karchmer T, et al. Public health initiative to control MRSA and VRE in Virginia and North Carolina. In: Program and abstracts of the 11th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 1-3,2001; Toronto. Abstract 164.
27. Jernigan JA, Clemence MA, Stott GA, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol. 1995;16:686-696.
28. Coello R, Glynn JR, Gaspar C, et al. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect. 1997;37:39-46.
29. Calfee DP, Giannetta. E, Farr BM. Effective control of VRE colonization using CDC recommendations for detection and isolation. In: Program and abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America; September 7-10, 2000; New Orleans. Abstract 21.
30. Larson E, Early E, Cloonan P, et al. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med. 2000;26:14-22.
31. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000;356:1307-1312.
32. Harbarth S, Martin Y, Rohner P, et al. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2000;46:43-49.
33. Austin DJ, Bonten MJM, Weinstein RA, et al. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A. 1999;96:6908-6913.
34. Byers KE, Durbin LJ, Simonton BM, et al. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 1998;19:261-264.
35. Marinella M, Pierson C, Chenoweth C. The stethoscope: a potential source of nosocomial infection? Arch Intern Med. 1997;157:786-790.
36. Garner JS, Simmons BP. Guideline for isolation precautions in hospitals. Infect Control. 1983; 4(suppl 4):245-325.
37. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA. 1999;282: 1745-1751.
38. Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med. 1999;131:269-272.
39. Recommendations for preventing the spread of vancomycin resistance. MMWR. 1995;44(RR-12): 1-13.
40. Ostrowsky B, Trick W, Sohn AH, et al. Control of vancomycin-resistant Enterococcus in a region. N Engl J Med. 2001;344:1427-1433.
41. Monnet D. Control of antibiotic resistance in Europe. Presented at: Global Conference on Antibiotic Resistance; March 19-21, 1999; Toronto.
42. Jans B, Suetens C, Struelens M. Decreasing MRSA rates in Belgian hospitals: results from the national surveillance network after introduction of national guidelines. Infect Control Hosp Epidemiol. 2000;21:419.
43. Montecalvo MA, Jarvis WR, Uman J, et al. Costs and savings associated with infection control measures that reduced transmissions of vancomycin-resistant enterococci in an endemic setting. Infect Control Hosp Epidemiol. 2001; 22:437-442.